212 related articles for article (PubMed ID: 31358938)
1. Distinct prognostic value of circulating anti-telomerase CD4
Laheurte C; Dosset M; Vernerey D; Boullerot L; Gaugler B; Gravelin E; Kaulek V; Jacquin M; Cuche L; Eberst G; Jacoulet P; Fabre E; Le Pimpec-Barthes F; Tartour E; De Carvalho Bittencourt M; Westeel V; Adotévi O
Br J Cancer; 2019 Aug; 121(5):405-416. PubMed ID: 31358938
[TBL] [Abstract][Full Text] [Related]
2. Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.
Godet Y; Fabre E; Dosset M; Lamuraglia M; Levionnois E; Ravel P; Benhamouda N; Cazes A; Le Pimpec-Barthes F; Gaugler B; Langlade-Demoyen P; Pivot X; Saas P; Maillère B; Tartour E; Borg C; Adotévi O
Clin Cancer Res; 2012 May; 18(10):2943-53. PubMed ID: 22407833
[TBL] [Abstract][Full Text] [Related]
3. Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients.
Juliá EP; Mandó P; Rizzo MM; Cueto GR; Tsou F; Luca R; Pupareli C; Bravo AI; Astorino W; Mordoh J; Martín C; Levy EM
Cancer Immunol Immunother; 2019 Oct; 68(10):1585-1596. PubMed ID: 31515670
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.
Boustani J; Joseph ELM; Martin E; Benhmida S; Lecoester B; Tochet F; Mirjolet C; Chevalier C; Thibouw D; Vulquin N; Servagi S; Sun X; Adotévi O
BMC Immunol; 2021 Jun; 22(1):38. PubMed ID: 34144673
[TBL] [Abstract][Full Text] [Related]
5. CD4
Kagamu H; Kitano S; Yamaguchi O; Yoshimura K; Horimoto K; Kitazawa M; Fukui K; Shiono A; Mouri A; Nishihara F; Miura Y; Hashimoto K; Murayama Y; Kaira K; Kobayashi K
Cancer Immunol Res; 2020 Mar; 8(3):334-344. PubMed ID: 31871122
[TBL] [Abstract][Full Text] [Related]
6. Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Nardin C; Laheurte C; Puzenat E; Boullerot L; Ramseyer M; Marguier A; Jacquin M; Godet Y; Aubin F; Adotevi O
J Invest Dermatol; 2022 Feb; 142(2):435-444. PubMed ID: 34352265
[TBL] [Abstract][Full Text] [Related]
7. Increased exhausted CD8
Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
[TBL] [Abstract][Full Text] [Related]
8. Response to Chemoimmunotherapy Is Associated With Expansion of Systemic Antitumor CD4 + Th1 Response in Metastatic Non-Small Cell Lung Cancer.
Wespiser M; Marguier A; Lecoester B; Richard T; Boullerot L; Malfroy M; Kumar A; Laheurte C; Adotévi O
J Immunother; 2023 Sep; 46(7):279-283. PubMed ID: 36799899
[TBL] [Abstract][Full Text] [Related]
9. [Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer].
Ji P; Chen D; Bian J; Xia R; Song X; Wen W; Zhang X; Zhu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):808-11. PubMed ID: 26062425
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial Tim-3 and PD-1 activity sustains antigen-specific Th1 cell numbers during blood-stage malaria.
Dookie RS; Villegas-Mendez A; Kroeze H; Barrett JR; Draper SJ; Franke-Fayard BM; Janse CJ; MacDonald AS; Couper KN
Parasite Immunol; 2020 Sep; 42(9):e12723. PubMed ID: 32306409
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5
Ma QY; Huang DY; Zhang HJ; Wang S; Chen XF
Int Immunopharmacol; 2017 Nov; 52():305-309. PubMed ID: 28982050
[TBL] [Abstract][Full Text] [Related]
12. Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.
Datta J; Berk E; Xu S; Fitzpatrick E; Rosemblit C; Lowenfeld L; Goodman N; Lewis DA; Zhang PJ; Fisher C; Roses RE; DeMichele A; Czerniecki BJ
Breast Cancer Res; 2015 May; 17(1):71. PubMed ID: 25997452
[TBL] [Abstract][Full Text] [Related]
13. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
[TBL] [Abstract][Full Text] [Related]
14. 1α,25(OH)
Li P; Zhu X; Cao G; Wu R; Li K; Yuan W; Chen B; Sun G; Xia X; Zhang H; Wang X; Yin Z; Lu L; Gao Y
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35318258
[TBL] [Abstract][Full Text] [Related]
15. Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor.
Dosset M; Godet Y; Vauchy C; Beziaud L; Lone YC; Sedlik C; Liard C; Levionnois E; Clerc B; Sandoval F; Daguindau E; Wain-Hobson S; Tartour E; Langlade-Demoyen P; Borg C; Adotévi O
Clin Cancer Res; 2012 Nov; 18(22):6284-95. PubMed ID: 23032748
[TBL] [Abstract][Full Text] [Related]
16. Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling.
Rice SJ; Liu X; Zhang J; Jia B; Zheng H; Belani CP
Lung Cancer; 2019 May; 131():58-61. PubMed ID: 31027698
[TBL] [Abstract][Full Text] [Related]
17. Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.
Gorman JV; Colgan JD
Immunology; 2018 Jul; 154(3):418-433. PubMed ID: 29315553
[TBL] [Abstract][Full Text] [Related]
18. Anti-Telomerase CD4
Spehner L; Kim S; Vienot A; François E; Buecher B; Adotevi O; Vernerey D; Abdeljaoued S; Meurisse A; Borg C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957741
[TBL] [Abstract][Full Text] [Related]
19. The distribution and function of human memory T cell subsets in lung cancer.
Sheng SY; Gu Y; Lu CG; Zou JY; Hong H; Wang R
Immunol Res; 2017 Jun; 65(3):639-650. PubMed ID: 28101811
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer.
Ito N; Suzuki Y; Taniguchi Y; Ishiguro K; Nakamura H; Ohgi S
Anticancer Res; 2005; 25(3B):2027-31. PubMed ID: 16158940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
